Literature DB >> 2976083

Premature aging changes in neuromuscular junctions of transgenic mice with an extra human CuZnSOD gene: a model for tongue pathology in Down's syndrome.

R Yarom1, D Sapoznikov, Y Havivi, K B Avraham, M Schickler, Y Groner.   

Abstract

We examined the tongue muscles in several strains of transgenic mice carrying the human Zn-Cu superoxide dismutase (CuZnSOD) gene. The presence of the extra gene was confirmed in mated progeny and the gene product activity was measured in the tongue and found to be much higher than in normal littermate controls. Using electron microscopic morphometry, the neuromuscular junctions of the transgenic mice showed significant changes resembling excessive aging, with atrophy, degeneration, withdrawal, and sometimes destruction of the terminal axons, as well as the development of multiple small terminals. The myofibers showed little change except for slight hypertrophy and an increased variability in size. They also had more megamitochondria, fat droplets and lipofuscin bodies. Excess CuZnSOD generates H2O2 and hydroxyl radicals which affect both NMJ membranes and plasticity, and which may produce premature aging. The findings resemble those observed in tongues of patients with Down's syndrome, in whom an extra CuZnSOD gene is present as part of the trisomy of chromosome 21.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2976083     DOI: 10.1016/0022-510x(88)90204-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  Pro-oxidant activity of Cu,Zn-superoxide dismutase.

Authors:  M B Yim; H S Yim; P Boon Chock; E R Stadtman
Journal:  Age (Omaha)       Date:  1998-04

2.  Oxidative stress mediates impairment of muscle function in transgenic mice with elevated level of wild-type Cu/Zn superoxide dismutase.

Authors:  M Peled-Kamar; J Lotem; I Wirguin; L Weiner; A Hermalin; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Constitutive overexpression of Cu/Zn superoxide dismutase exacerbates kainic acid-induced apoptosis of transgenic-Cu/Zn superoxide dismutase neurons.

Authors:  O Bar-Peled; E Korkotian; M Segal; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

4.  Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.

Authors:  Margaret Wong; Lee J Martin
Journal:  Hum Mol Genet       Date:  2010-03-10       Impact factor: 6.150

Review 5.  Hydrogen peroxide as a diffusible signal molecule in synaptic plasticity.

Authors:  Ariel Kamsler; Menahem Segal
Journal:  Mol Neurobiol       Date:  2004-04       Impact factor: 5.590

6.  Thermosensitive phenotype of transgenic mice overproducing human glutathione peroxidases.

Authors:  O Mirochnitchenko; U Palnitkar; M Philbert; M Inouye
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

7.  A comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective function.

Authors:  Siranush A Sargsyan; Daniel J Blackburn; Siân C Barber; Julian Grosskreutz; Kurt J De Vos; Peter N Monk; Pamela J Shaw
Journal:  BMC Neurosci       Date:  2011-09-23       Impact factor: 3.288

8.  Gene dosage of CuZnSOD and Down's syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice.

Authors:  D Minc-Golomb; H Knobler; Y Groner
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

9.  Diminished serotonin uptake in platelets of transgenic mice with increased Cu/Zn-superoxide dismutase activity.

Authors:  M Schickler; H Knobler; K B Avraham; O Elroy-Stein; Y Groner
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

10.  Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu/Zn-superoxide dismutase: implications for Down syndrome.

Authors:  M Peled-Kamar; J Lotem; E Okon; L Sachs; Y Groner
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.